Amneal Pharmaceuticals, Inc. (AMRX)
12.46
+0.25
(+2.05%)
USD |
NASDAQ |
Dec 15, 16:00
12.35
-0.11
(-0.88%)
After-Hours: 06:45
Amneal Pharmaceuticals Research and Development Expense (Annual): 190.71M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AbbVie, Inc. | 8.315B |
| Johnson & Johnson | 17.26B |
| Amgen, Inc. | 5.676B |
| United Therapeutics Corp. | 481.00M |
| Xeris Biopharma Holdings, Inc. | 25.56M |